Yale Cancer Center researchers receive grants from the Kidney Cancer Society

Yale Cancer Center researchers receive grants from the Kidney Cancer Society

David Brown, MD, PhD, assistant professor of medicine (medical oncology), Lewis Goodman and Alfred Gilman Yale Scholar, and Nazli Desman, MD, residency in internal medicine at Yale University School of Medicine, received Trailblazers Kidney Cancer Awards organisation. The awards support researchers pursuing projects that improve kidney cancer treatment and care.

Dr. Brown is interested in kidney cancer patients and his research focuses primarily on integrating experimental and computational methods into biomedical research. He is also a member of the Center for Molecular and Cellular Oncology at Yale University. The title of his project is, “The Immunobiology Anatomy of Chromophobic Renal Cell Carcinomas Using Single-Cell Transcripts.”

Dr. Desman’s research focuses on targeted molecular therapy, drug-related side effects and adverse reactions, and consideration of the gastrointestinal microbiome. Dr. Desman recently led a study evaluating the effect of dietary interventions on the gut microbiome in patients with metastatic renal cell carcinoma receiving immunotherapies. Her current project is entitled “Effect of CBM588 on the metabolic profile in patients with metastatic renal cell carcinoma (mRCC).”

Read:A Fresh Take on Cardiovascular Medicine

The Trailblazer Prize is a new award category from the Kidney Cancer Society this year and funds promising young to mid-career researchers to advance innovative kidney cancer research. The Kidney Cancer Society is a global community dedicated to serving and empowering patients and caregivers, and driving change through advocacy, research, and education in order to be a global leader in finding a cure for kidney cancer.

Previous post
Not all conservatives will welcome Truss’ big tax gamble | News
Next post
Tony is one of five out of England’s Nations League squad against Italy